Indonesia Penalizes Kalbe Over Suspected Drug Mix-Up Deaths
This article was originally published in PharmAsia News
Executive Summary
Indonesia’s food and drug agency has ordered the country’s largest pharmaceutical company, Kalbe Farma, to suspend production of some of its drugs over a suspected label mix-up that led to the death of two patients.